NBIX
Neurocrine Biosciences, Inc.
$162.86−3.06 (−1.84%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
May 23, 1996 – Nov 18, 2026, Dividends reinvested
- Final balance
- $130,288
- CAGR
- +8.78%
- Max drawdown
- −97.21%
Trailing returns (%)
NBIX's average annual return was 12.31% over the last 10 years and 15.18% over the last 20 years, through Nov 18, 2026. $10,000 in NBIX on Nov 18, 2016 grew to $31,927 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +20.01%
- 3M
- +5.60%
- 6M
- +3.59%
- YTD
- +14.83%
- 1Y
- +17.48%
Per year
- 3Y
- +14.34%
- 5Y
- +13.23%
- 10Y
- +12.31%
- 15Y
- +24.29%
- 20Y
- +15.18%
- 25Y
- +5.61%
- 30Y
- +9.48%
- Since 1996
- +8.78%
Annual returns
1996 from May 23 · 2026 through Nov 18
NBIX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +14.83% |
| 2025 | +3.90% |
| 2024 | +3.60% |
| 2023 | +10.31% |
| 2022 | +40.24% |
| 2021 | −11.14% |
| 2020 | −10.83% |
| 2019 | +50.53% |
| 2018 | −7.96% |
| 2017 | +100.49% |
| 2016 | −31.59% |
| 2015 | +153.22% |
Metrics
Since 1996| Volatility | 61.28% |
|---|---|
| Sharpe ratio | 0.45 |
| Sortino ratio | 0.68 |
| Calmar ratio | 0.09 |
| Longest drawdown | 11.6 years |
Worst drawdowns
Since 1996| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −97.2% | Mar 2006 | Nov 2009 | Nov 2017 | 11.6 years |
| −70.3% | Feb 1997 | Jul 1999 | Nov 1999 | 2.7 years |
| −66.2% | Mar 2000 | Mar 2001 | Nov 2001 | 1.7 years |
| −54.1% | Dec 2001 | Jul 2002 | Jun 2003 | 1.4 years |
| −50.7% | Apr 2004 | May 2005 | Feb 2006 | 1.8 years |